Medical Devices
CIRS Group
Chemicals
Cosmetic
Food
Medical Devices
Agrochemicals
C&K Testing
Carbon Neutrality
Search

CFDA Post-marketing Supervision-- Medical Device Quality Sampling (Jan-Sep, 2017)

by
In order to strengthen medical devices quality supervision and management and ensure the product safety and effectiveness, CFDA keep conducting inspections within certain interval.

CFDA Regulation Background
The Statistic about Medical Device Quality Sampling
Medical device quality announcement issued timeThe amount of category for spot checkSpot check sample sizeThe disqualification amount of label and manualThe disqualification percentage of label and manual (%)
09/14/2017255712.73
09/07/201711452517.24
08/31/2017148816.67
08/21/2017315553.23
08/08/2017320241.98
07/21/2017515042.67
07/10/201719400.00
06/21/2017324720.81
06/14/2017220600.00
05/24/2017141819.51
05/10/2017214764.08
05/08/201735911.69
04/26/201715800.00
04/19/201725400.00
04/11/201727800.00
04/06/2017212800.00
03/28/201767922.53
03/14/20172122200.00
02/23/201746323.17
02/15/201764724.26
01/20/201758111.23





Based on the statistcs, CFDA keep strengthening their supervision on the medical device. And medical device label and manual compiling is still a challenge for the manufactures.
* If you have any questions about medical device label and manual compiling, please feel free to contact CIRS at md@cirs-group.com.

  

We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.

Contact Us
+86 571 8720 6559 (GMT+8 8:30~17:00)
Contact Us
+86 571 8720 6559 (GMT+8 8:30~17:00)